您当前的位置：
首页 >
文章列表页 >
Positron radioactive molecular imaging agents for early diagnosis of Parkinson’s disease
更新时间：2021-03-05
|

    • Positron radioactive molecular imaging agents for early diagnosis of Parkinson’s disease

    • NUCLEAR TECHNIQUES   Vol. 35, Issue 3, (2012)
    • CLC： R742.5;R817.4

    • Published：01 March 2012

    移动端阅览

  • LI Yinghua GUAN Feng DAI Yuyin LIN Chenghe. Positron radioactive molecular imaging agents for early diagnosis of Parkinson’s disease[J]. Nuclear techniques, 2012, 35(3): 211-215. DOI：

  •  
  •  

0

Views

22

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Value of the dual phase 18F-FDG PET/CT with oral diuretic in the diagnosis of bladder cancer before therapy
SPECT/CT fusion imaging for differential diagnosis of bone solitary metastases in patients with lung cancer
18F-FDG PET/CT imaging and diagnosis method of small intestine primary malignant neoplasms
The added value of SPECT/CT fusion imaging for differential diagnosis of bone metastases in patients with hepatocellular carcinoma
Applications of radiolabeled somatostatin analogs in the diagnosis and therapy of thyroid cancer

Related Author

WU Hubing
WANG Qiaoyu
HAN Yanjiang
WANG Quanshi
LI Hongsheng
CHANG Cheng
FENG Jian
LIU Ciyi

Related Institution

PET Center, Nanfang Hospital, Southern Medical University
Department of Nuclear Medicine,Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University
Department of Thoracic Surgery,Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University
Department of Nuclear Medicine,the Baoan Hospital Affiliated to Nangfang Medical University,Shenzhen 518101,China) 2
广州军区广州总医院核医学科
0